Clinical Trials Sponsored by MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute

Total 3 results

MidAmerica Neuroscience Research Foundation at...
Consultants in Neurology

Withdrawn

Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.

Multiple Sclerosis | Optic Neuritis | Neuritis | Myelitis | Demyelinating Disorders

United States
MidAmerica Neuroscience Research Foundation at...
Biogen; Consultants in Neurology

Completed

Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis (MTX01)

Multiple Sclerosis
MidAmerica Neuroscience Research Foundation at...
University of Missouri, Kansas City

Withdrawn

Progression of Cognitive and Physical Symptoms in Multiple Sclerosis

Multiple Sclerosis

3

Subscribe